XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
 12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Cash flows from operating activities:    
Net loss $ (9,214) $ (14,466)
Adjustments to reconcile loss to net cash provided by operations:    
Depreciation and amortization 19,135 18,708
Amortization of operating lease assets 1,481 1,702
Amortization of debt financing costs and discount 820 718
Net accretion of discounts and amortization of premiums on available-for-sale securities (119) 280
Provision for expected losses 2,047 803
Provision for (recovery of) deferred income taxes 225 (92)
Gain (Loss) on Extinguishment of Debt, Operational (990) 0
Debt Securities, Available-for-sale, Realized Gain (Loss) (2,257) (1,221)
Share-based compensation 5,430 3,179
Loss on disposals of long-term assets 132 25
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 175 (1,245)
Finite-Lived Intangible Assets, Purchase Accounting Adjustments 0 18
Changes in operating assets and liabilities:    
Accounts receivable (4,126) (7,618)
Inventory 97 (14)
Prepaid expenses and other assets 5,101 2,993
Increase (Decrease) in Other Operating Assets 546 (3,020)
Accounts payable 376 1,611
Accrued expenses and other long-term obligations 87 3,828
Operating lease liabilities (1,118) 2,023
Deferred revenue (2,379) 5,462
Net cash provided by operating activities 18,900 13,674
Cash flows from investing activities:    
Acquisition of intangible assets (7,651) (2,289)
Purchases of property and equipment (1,585) (2,318)
Software capitalization costs (7,027) (4,228)
Payments to Acquire Debt Securities, Available-for-sale (27,647) (37,232)
Proceeds from sales and maturities of available-for-sale securities 14,385 10,068
Net cash used in investing activities (29,525) (35,999)
Cash flows from financing activities:    
Payments of notes payable (35,627) (1,688)
Payment for Contingent Consideration Liability, Financing Activities 0 (130)
Payments of Financing Costs (250) 0
Net proceeds from issuance of common stock 46,800 497
Net change in client fund obligations 13,931 (11,055)
Net cash provided by (used) in financing activities 24,205 (12,376)
Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents 13,580 (34,701)
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period 164,042 198,743
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period 177,622 164,042
Cash, cash equivalents, and restricted cash 30,317 17,010
Restricted Cash and Cash Equivalents 147,305 147,032
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 177,622 164,042
Supplemental Cash Flow Information [Abstract]    
Interest Paid, Excluding Capitalized Interest, Operating Activities 3,140 3,397
Income Taxes Paid 432 233
Subordinated notes payable –acquisitions 1,209 411
Stock Issued 2,543 0
Other Noncash Expense 1,471 0
Payment Of Stock Issuance Costs, Capital Raise Fees (338) 0
Repayments of Long-Term Loans from Vendors (311) 0
Noncash or Part Noncash Acquisition, Value of Assets Acquired $ 357 $ 0